Alnylam Pharmaceuticals, Inc. - 0306060, Assessing Patients' Experiences With Acute Hepatic Porphyria: Exit Interviews (Pro00053618)

Project: Research project

Project Details

StatusFinished
Effective start/end date10/6/21 → 10/5/24

Funding

  • Alnylam Pharmaceuticals, Inc: $1,800.00